Back to SGMT

GOLDMAN SACHS GROUP INC → SGMT

GOLDMAN SACHS GROUP INC SGMT Position History

Sagimet Biosciences Inc. • Healthcare

Quarters held
9
Latest value
$564K
Q2 2026
Peak value
$5.3M
First seen
Q1 2025

Dollar value over time

Show data table
PeriodPosition value
Q1 2025$77K
Q2 2025$142K
Q3 2025$104K
Q4 2025$746K
Q4 2025$746K
Q1 2026$790K
Q1 2026$95K
Q2 2026$5.3M
Q2 2026$564K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$564K73.0K——
Q2 2026$5.3M686.1K——
Q1 2026$95K18.1K——
Q1 2026$790K151.1K——
Q4 2025$746K125.9K——
Q4 2025$746K125.9K——
Q3 2025$104K15.2K——
Q2 2025$142K18.6K——
Q1 2025$77K23.6K——

Other funds holding SGMT

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B
AAPL

APPLE INC

$23.8B
AAPL

APPLE INC

$23.8B